Man Group
TCRX icon

Man Group’s TScan Therapeutics TCRX Stock Holding History

Man Group’s Portfolio TCRX Stock Details TCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18,651
Closed -$109K – 2051
2024
Q2 		$109K Sell
18,651
-58,688
-76% -$343K ﹤0.01% 1816
2024
Q1 		$614K Buy
77,339
+26,929
+53% +$214K ﹤0.01% 1599
2023
Q4 		$294K Buy
+50,410
New +$294K ﹤0.01% 1700